美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 30 条
共 2 页，当前第 2 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| RITONAVIR |
205801 |
001 |
ANDA |
RITONAVIR |
CAPSULE;ORAL |
100MG |
No
|
No
|
2020/12/03
|
2020/12/03
|
HIKMA |
Discontinued |
| LOPINAVIR AND RITONAVIR |
091677 |
001 |
ANDA |
LOPINAVIR; RITONAVIR |
TABLET;ORAL |
100MG;25MG |
No
|
No
|
2021/06/04
|
2021/06/04
|
HETERO LABS LTD III |
Prescription |
| LOPINAVIR AND RITONAVIR |
091677 |
002 |
ANDA |
LOPINAVIR; RITONAVIR |
TABLET;ORAL |
200MG;50MG |
No
|
No
|
2021/06/04
|
2021/06/04
|
HETERO LABS LTD III |
Prescription |
| LOPINAVIR AND RITONAVIR |
213857 |
001 |
ANDA |
LOPINAVIR; RITONAVIR |
TABLET;ORAL |
100MG;25MG |
No
|
No
|
2022/03/21
|
2022/03/21
|
LAURUS |
Prescription |
| LOPINAVIR AND RITONAVIR |
213857 |
002 |
ANDA |
LOPINAVIR; RITONAVIR |
TABLET;ORAL |
200MG;50MG |
No
|
No
|
2022/03/21
|
2022/03/21
|
LAURUS |
Prescription |
| RITONAVIR |
203759 |
001 |
ANDA |
RITONAVIR |
TABLET;ORAL |
100MG |
No
|
No
|
2022/05/10
|
2022/05/10
|
CIPLA |
Prescription |
| DARUNAVIR AND RITONAVIR |
209847 |
001 |
NDA |
DARUNAVIR AND RITONAVIR |
TABLET; ORAL |
400MG/50MG |
No
|
No
|
2023/12/22
(TA)
|
--
|
MYLAN PHARMS INC |
Prescription |
| LOPINAVIR AND RITONAVIR |
079074 |
001 |
ANDA |
LOPINAVIR; RITONAVIR |
TABLET;ORAL |
100MG;25MG |
No
|
No
|
2024/02/07
|
2024/02/07
|
MYLAN LABS LTD |
Prescription |
| LOPINAVIR AND RITONAVIR |
079074 |
002 |
ANDA |
LOPINAVIR; RITONAVIR |
TABLET;ORAL |
200MG;50MG |
No
|
No
|
2024/02/07
|
2024/02/07
|
MYLAN LABS LTD |
Prescription |
| RITONAVIR |
205024 |
001 |
ANDA |
RITONAVIR |
CAPSULE;ORAL |
100MG |
No
|
No
|
2024/02/16
|
2024/02/16
|
MYLAN |
Prescription |